nodes	percent_of_prediction	percent_of_DWPC	metapath
Crizotinib—NEK9—forebrain—narcolepsy	0.0108	0.0188	CbGeAlD
Crizotinib—PRKD1—forebrain—narcolepsy	0.00983	0.0171	CbGeAlD
Crizotinib—ROS1—brain—narcolepsy	0.00901	0.0157	CbGeAlD
Crizotinib—MAPK7—forebrain—narcolepsy	0.00873	0.0152	CbGeAlD
Crizotinib—MET—brainstem—narcolepsy	0.00847	0.0148	CbGeAlD
Crizotinib—EPHA7—brain—narcolepsy	0.00824	0.0144	CbGeAlD
Crizotinib—ACVR1B—forebrain—narcolepsy	0.00756	0.0132	CbGeAlD
Crizotinib—NTRK1—midbrain—narcolepsy	0.00753	0.0131	CbGeAlD
Crizotinib—DCLK1—forebrain—narcolepsy	0.00716	0.0125	CbGeAlD
Crizotinib—PRKD1—medulla oblongata—narcolepsy	0.0071	0.0124	CbGeAlD
Crizotinib—TYRO3—brainstem—narcolepsy	0.00693	0.0121	CbGeAlD
Crizotinib—TYRO3—forebrain—narcolepsy	0.00669	0.0117	CbGeAlD
Crizotinib—EPHA5—forebrain—narcolepsy	0.00669	0.0117	CbGeAlD
Crizotinib—IGF1R—brainstem—narcolepsy	0.00666	0.0116	CbGeAlD
Crizotinib—TNK2—forebrain—narcolepsy	0.00643	0.0112	CbGeAlD
Crizotinib—IGF1R—forebrain—narcolepsy	0.00643	0.0112	CbGeAlD
Crizotinib—LIMK1—midbrain—narcolepsy	0.00641	0.0112	CbGeAlD
Crizotinib—DSTYK—midbrain—narcolepsy	0.00609	0.0106	CbGeAlD
Crizotinib—MAP3K12—brainstem—narcolepsy	0.00589	0.0103	CbGeAlD
Crizotinib—MERTK—forebrain—narcolepsy	0.00588	0.0103	CbGeAlD
Crizotinib—STK35—brainstem—narcolepsy	0.00577	0.0101	CbGeAlD
Crizotinib—BMP2K—forebrain—narcolepsy	0.00536	0.00935	CbGeAlD
Crizotinib—PTK2B—forebrain—narcolepsy	0.00518	0.00903	CbGeAlD
Crizotinib—DCLK1—medulla oblongata—narcolepsy	0.00518	0.00903	CbGeAlD
Crizotinib—EPHA4—brainstem—narcolepsy	0.00515	0.00897	CbGeAlD
Crizotinib—EPHA4—forebrain—narcolepsy	0.00497	0.00866	CbGeAlD
Crizotinib—ALK—medulla oblongata—narcolepsy	0.00483	0.00843	CbGeAlD
Crizotinib—EPHA5—medulla oblongata—narcolepsy	0.00483	0.00843	CbGeAlD
Crizotinib—FER—medulla oblongata—narcolepsy	0.00483	0.00843	CbGeAlD
Crizotinib—PTK2—forebrain—narcolepsy	0.00477	0.00832	CbGeAlD
Crizotinib—DCLK1—midbrain—narcolepsy	0.00473	0.00825	CbGeAlD
Crizotinib—RPS6KB1—forebrain—narcolepsy	0.00459	0.008	CbGeAlD
Crizotinib—MAP4K2—medulla oblongata—narcolepsy	0.00458	0.00798	CbGeAlD
Crizotinib—NEK9—brain—narcolepsy	0.00448	0.00781	CbGeAlD
Crizotinib—FER—midbrain—narcolepsy	0.00442	0.0077	CbGeAlD
Crizotinib—EPHA5—midbrain—narcolepsy	0.00442	0.0077	CbGeAlD
Crizotinib—ALK—midbrain—narcolepsy	0.00442	0.0077	CbGeAlD
Crizotinib—TESK1—medulla oblongata—narcolepsy	0.00436	0.00761	CbGeAlD
Crizotinib—JAK2—forebrain—narcolepsy	0.00431	0.00752	CbGeAlD
Crizotinib—MAP4K2—midbrain—narcolepsy	0.00418	0.0073	CbGeAlD
Crizotinib—MAP4K5—forebrain—narcolepsy	0.00415	0.00724	CbGeAlD
Crizotinib—MAP3K12—medulla oblongata—narcolepsy	0.00411	0.00717	CbGeAlD
Crizotinib—ACVR1—medulla oblongata—narcolepsy	0.00411	0.00717	CbGeAlD
Crizotinib—PRKD1—brain—narcolepsy	0.00408	0.00712	CbGeAlD
Crizotinib—SIK2—brain—narcolepsy	0.00403	0.00702	CbGeAlD
Crizotinib—LIMK1—brain—narcolepsy	0.00403	0.00702	CbGeAlD
Crizotinib—TESK1—midbrain—narcolepsy	0.00399	0.00696	CbGeAlD
Crizotinib—EPHB6—forebrain—narcolepsy	0.00397	0.00692	CbGeAlD
Crizotinib—TAOK3—brainstem—narcolepsy	0.00392	0.00684	CbGeAlD
Crizotinib—PRKD3—brain—narcolepsy	0.00392	0.00684	CbGeAlD
Crizotinib—DSTYK—brain—narcolepsy	0.00383	0.00668	CbGeAlD
Crizotinib—TAOK3—forebrain—narcolepsy	0.00379	0.00661	CbGeAlD
Crizotinib—ACVR1—midbrain—narcolepsy	0.00376	0.00655	CbGeAlD
Crizotinib—MAP3K12—midbrain—narcolepsy	0.00376	0.00655	CbGeAlD
Crizotinib—LTK—brain—narcolepsy	0.00374	0.00653	CbGeAlD
Crizotinib—CASK—brain—narcolepsy	0.00374	0.00653	CbGeAlD
Crizotinib—RIPK2—medulla oblongata—narcolepsy	0.00371	0.00647	CbGeAlD
Crizotinib—SRC—forebrain—narcolepsy	0.00369	0.00644	CbGeAlD
Crizotinib—STK35—midbrain—narcolepsy	0.00368	0.00642	CbGeAlD
Crizotinib—MAPK7—brain—narcolepsy	0.00362	0.00632	CbGeAlD
Crizotinib—EPHA4—medulla oblongata—narcolepsy	0.00359	0.00626	CbGeAlD
Crizotinib—EPHA8—brain—narcolepsy	0.00359	0.00626	CbGeAlD
Crizotinib—FES—brain—narcolepsy	0.00359	0.00626	CbGeAlD
Crizotinib—BMP2K—midbrain—narcolepsy	0.00354	0.00618	CbGeAlD
Crizotinib—TBK1—medulla oblongata—narcolepsy	0.00345	0.00601	CbGeAlD
Crizotinib—TYK2—medulla oblongata—narcolepsy	0.00342	0.00597	CbGeAlD
Crizotinib—MET—brain—narcolepsy	0.00339	0.00592	CbGeAlD
Crizotinib—RIPK2—midbrain—narcolepsy	0.00339	0.00592	CbGeAlD
Crizotinib—RPS6KB1—medulla oblongata—narcolepsy	0.00331	0.00578	CbGeAlD
Crizotinib—CSF1R—forebrain—narcolepsy	0.00331	0.00578	CbGeAlD
Crizotinib—AXL—medulla oblongata—narcolepsy	0.00328	0.00572	CbGeAlD
Crizotinib—CDK7—brain—narcolepsy	0.00328	0.00572	CbGeAlD
Crizotinib—TAOK2—brain—narcolepsy	0.00326	0.00568	CbGeAlD
Crizotinib—SLK—medulla oblongata—narcolepsy	0.00316	0.00551	CbGeAlD
Crizotinib—TBK1—midbrain—narcolepsy	0.00315	0.00549	CbGeAlD
Crizotinib—PTK2—midbrain—narcolepsy	0.00315	0.00549	CbGeAlD
Crizotinib—EPHB4—medulla oblongata—narcolepsy	0.00314	0.00547	CbGeAlD
Crizotinib—ACVR1B—brain—narcolepsy	0.00314	0.00547	CbGeAlD
Crizotinib—EPHA3—brain—narcolepsy	0.00314	0.00547	CbGeAlD
Crizotinib—TYK2—midbrain—narcolepsy	0.00313	0.00546	CbGeAlD
Crizotinib—JAK2—medulla oblongata—narcolepsy	0.00311	0.00543	CbGeAlD
Crizotinib—IRAK1—midbrain—narcolepsy	0.00309	0.00538	CbGeAlD
Crizotinib—RPS6KB1—midbrain—narcolepsy	0.00303	0.00528	CbGeAlD
Crizotinib—MAP3K3—medulla oblongata—narcolepsy	0.003	0.00523	CbGeAlD
Crizotinib—TEK—medulla oblongata—narcolepsy	0.003	0.00523	CbGeAlD
Crizotinib—MAP4K5—medulla oblongata—narcolepsy	0.003	0.00523	CbGeAlD
Crizotinib—AXL—midbrain—narcolepsy	0.003	0.00523	CbGeAlD
Crizotinib—EPHA6—brain—narcolepsy	0.00299	0.00522	CbGeAlD
Crizotinib—JAK3—brain—narcolepsy	0.00299	0.00522	CbGeAlD
Crizotinib—DCLK1—brain—narcolepsy	0.00297	0.00518	CbGeAlD
Crizotinib—PLK4—brain—narcolepsy	0.00295	0.00515	CbGeAlD
Crizotinib—STK4—brain—narcolepsy	0.00294	0.00512	CbGeAlD
Crizotinib—SLK—midbrain—narcolepsy	0.00289	0.00504	CbGeAlD
Crizotinib—EPHB6—medulla oblongata—narcolepsy	0.00287	0.005	CbGeAlD
Crizotinib—EPHB4—midbrain—narcolepsy	0.00287	0.005	CbGeAlD
Crizotinib—EPHA5—brain—narcolepsy	0.00278	0.00484	CbGeAlD
Crizotinib—TYRO3—brain—narcolepsy	0.00278	0.00484	CbGeAlD
Crizotinib—FER—brain—narcolepsy	0.00278	0.00484	CbGeAlD
Crizotinib—ALK—brain—narcolepsy	0.00278	0.00484	CbGeAlD
Crizotinib—YES1—medulla oblongata—narcolepsy	0.00277	0.00483	CbGeAlD
Crizotinib—LYN—brain—narcolepsy	0.00276	0.00482	CbGeAlD
Crizotinib—TNK1—brain—narcolepsy	0.00275	0.00479	CbGeAlD
Crizotinib—TEK—midbrain—narcolepsy	0.00274	0.00478	CbGeAlD
Crizotinib—MAP4K5—midbrain—narcolepsy	0.00274	0.00478	CbGeAlD
Crizotinib—MAP3K3—midbrain—narcolepsy	0.00274	0.00478	CbGeAlD
Crizotinib—TAOK3—medulla oblongata—narcolepsy	0.00274	0.00477	CbGeAlD
Crizotinib—MAP3K19—brain—narcolepsy	0.00272	0.00474	CbGeAlD
Crizotinib—MAP4K1—brain—narcolepsy	0.00272	0.00474	CbGeAlD
Crizotinib—BMPR1B—brain—narcolepsy	0.00272	0.00474	CbGeAlD
Crizotinib—ABL1—brainstem—narcolepsy	0.00271	0.00473	CbGeAlD
Crizotinib—TNK2—brain—narcolepsy	0.00267	0.00465	CbGeAlD
Crizotinib—IGF1R—brain—narcolepsy	0.00267	0.00465	CbGeAlD
Crizotinib—MAP4K2—brain—narcolepsy	0.00263	0.00459	CbGeAlD
Crizotinib—EPHB6—midbrain—narcolepsy	0.00262	0.00457	CbGeAlD
Crizotinib—TIE1—brain—narcolepsy	0.00259	0.00452	CbGeAlD
Crizotinib—STK3—brain—narcolepsy	0.00259	0.00452	CbGeAlD
Crizotinib—YES1—midbrain—narcolepsy	0.00253	0.00442	CbGeAlD
Crizotinib—AURKA—brain—narcolepsy	0.00253	0.00441	CbGeAlD
Crizotinib—TESK1—brain—narcolepsy	0.00251	0.00437	CbGeAlD
Crizotinib—TAOK3—midbrain—narcolepsy	0.0025	0.00436	CbGeAlD
Crizotinib—MERTK—brain—narcolepsy	0.00244	0.00425	CbGeAlD
Crizotinib—CSF1R—medulla oblongata—narcolepsy	0.00239	0.00418	CbGeAlD
Crizotinib—LIMK2—brain—narcolepsy	0.00238	0.00416	CbGeAlD
Crizotinib—NUAK2—brain—narcolepsy	0.00238	0.00414	CbGeAlD
Crizotinib—MAP3K12—brain—narcolepsy	0.00236	0.00412	CbGeAlD
Crizotinib—ACVR1—brain—narcolepsy	0.00236	0.00412	CbGeAlD
Crizotinib—STK35—brain—narcolepsy	0.00231	0.00403	CbGeAlD
Crizotinib—ABL2—brain—narcolepsy	0.00225	0.00393	CbGeAlD
Crizotinib—BMP2K—brain—narcolepsy	0.00223	0.00388	CbGeAlD
Crizotinib—CSF1R—midbrain—narcolepsy	0.00219	0.00382	CbGeAlD
Crizotinib—PTK2B—brain—narcolepsy	0.00215	0.00375	CbGeAlD
Crizotinib—RIPK2—brain—narcolepsy	0.00213	0.00372	CbGeAlD
Crizotinib—EPHA4—brain—narcolepsy	0.00206	0.00359	CbGeAlD
Crizotinib—MAP3K2—brain—narcolepsy	0.00202	0.00352	CbGeAlD
Crizotinib—PTK2—brain—narcolepsy	0.00198	0.00345	CbGeAlD
Crizotinib—TBK1—brain—narcolepsy	0.00198	0.00345	CbGeAlD
Crizotinib—TYK2—brain—narcolepsy	0.00197	0.00343	CbGeAlD
Crizotinib—IRAK1—brain—narcolepsy	0.00194	0.00338	CbGeAlD
Crizotinib—RPS6KB1—brain—narcolepsy	0.0019	0.00332	CbGeAlD
Crizotinib—ABL1—medulla oblongata—narcolepsy	0.00189	0.0033	CbGeAlD
Crizotinib—FGR—brain—narcolepsy	0.00189	0.0033	CbGeAlD
Crizotinib—AXL—brain—narcolepsy	0.00188	0.00329	CbGeAlD
Crizotinib—SLK—brain—narcolepsy	0.00181	0.00316	CbGeAlD
Crizotinib—EPHB4—brain—narcolepsy	0.0018	0.00314	CbGeAlD
Crizotinib—JAK2—brain—narcolepsy	0.00179	0.00312	CbGeAlD
Crizotinib—EPHA2—brain—narcolepsy	0.00177	0.00308	CbGeAlD
Crizotinib—ABL1—midbrain—narcolepsy	0.00173	0.00302	CbGeAlD
Crizotinib—MAP4K5—brain—narcolepsy	0.00172	0.00301	CbGeAlD
Crizotinib—MAP3K3—brain—narcolepsy	0.00172	0.00301	CbGeAlD
Crizotinib—TEK—brain—narcolepsy	0.00172	0.00301	CbGeAlD
Crizotinib—EPHB6—brain—narcolepsy	0.00165	0.00287	CbGeAlD
Crizotinib—YES1—brain—narcolepsy	0.00159	0.00278	CbGeAlD
Crizotinib—STK10—brain—narcolepsy	0.00158	0.00275	CbGeAlD
Crizotinib—TAOK3—brain—narcolepsy	0.00157	0.00274	CbGeAlD
Crizotinib—SRC—brain—narcolepsy	0.00153	0.00267	CbGeAlD
Crizotinib—CSF1R—brain—narcolepsy	0.00137	0.0024	CbGeAlD
Crizotinib—ABL1—brain—narcolepsy	0.00109	0.0019	CbGeAlD
Crizotinib—ABCB1—forebrain—narcolepsy	0.000814	0.00142	CbGeAlD
Crizotinib—ABCB1—medulla oblongata—narcolepsy	0.000588	0.00103	CbGeAlD
Crizotinib—ABCB1—midbrain—narcolepsy	0.000538	0.000938	CbGeAlD
Crizotinib—ABCB1—brain—narcolepsy	0.000338	0.000589	CbGeAlD
Crizotinib—PTK2—Signaling Pathways—HCRTR2—narcolepsy	0.000251	0.000589	CbGpPWpGaD
Crizotinib—LCK—Cytokine Signaling in Immune system—HLA-DQA1—narcolepsy	0.00025	0.000585	CbGpPWpGaD
Crizotinib—FES—Signaling Pathways—TAC1—narcolepsy	0.000249	0.000583	CbGpPWpGaD
Crizotinib—FES—Signaling Pathways—NPS—narcolepsy	0.000249	0.000583	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—HCRT—narcolepsy	0.000248	0.000581	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—HCRTR2—narcolepsy	0.000248	0.000581	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—HCRTR1—narcolepsy	0.000248	0.000581	CbGpPWpGaD
Crizotinib—MAPK7—Immune System—HLA-DQB1—narcolepsy	0.000245	0.000574	CbGpPWpGaD
Crizotinib—LIMK1—Immune System—HLA-DQB1—narcolepsy	0.000245	0.000574	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—P2RY11—narcolepsy	0.000243	0.000569	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—HCRT—narcolepsy	0.000241	0.000564	CbGpPWpGaD
Crizotinib—JAK2—Signaling by GPCR—HCRT—narcolepsy	0.00024	0.000564	CbGpPWpGaD
Crizotinib—TYK2—Signaling by GPCR—TRH—narcolepsy	0.00024	0.000564	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—P2RY11—narcolepsy	0.000239	0.000561	CbGpPWpGaD
Crizotinib—JAK2—GPCR downstream signaling—PENK—narcolepsy	0.000236	0.000553	CbGpPWpGaD
Crizotinib—STK3—Signaling Pathways—HTR2A—narcolepsy	0.000235	0.000552	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—HCRTR1—narcolepsy	0.000235	0.000551	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—HCRTR2—narcolepsy	0.000235	0.000551	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—PENK—narcolepsy	0.000234	0.000549	CbGpPWpGaD
Crizotinib—LCK—Cytokine Signaling in Immune system—HLA-DQB1—narcolepsy	0.000233	0.000547	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—PENK—narcolepsy	0.000231	0.000542	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—HCRTR2—narcolepsy	0.000228	0.000535	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—HCRTR1—narcolepsy	0.000228	0.000535	CbGpPWpGaD
Crizotinib—IRAK1—Regulation of toll-like receptor signaling pathway—TNF—narcolepsy	0.000228	0.000535	CbGpPWpGaD
Crizotinib—NTRK1—Integrated Pancreatic Cancer Pathway—TNF—narcolepsy	0.000227	0.000533	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—P2RY11—narcolepsy	0.000227	0.000532	CbGpPWpGaD
Crizotinib—IGF1R—Signaling Pathways—TAC1—narcolepsy	0.000225	0.000527	CbGpPWpGaD
Crizotinib—IGF1R—Signaling Pathways—NPS—narcolepsy	0.000225	0.000527	CbGpPWpGaD
Crizotinib—MAPK7—Signaling by GPCR—HTR2A—narcolepsy	0.000224	0.000525	CbGpPWpGaD
Crizotinib—JAK3—Signaling Pathways—TRH—narcolepsy	0.000224	0.000524	CbGpPWpGaD
Crizotinib—PTK2—Apoptosis—TNF—narcolepsy	0.000223	0.000524	CbGpPWpGaD
Crizotinib—MET—Developmental Biology—TNF—narcolepsy	0.000221	0.000518	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—PENK—narcolepsy	0.000221	0.000518	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—P2RY11—narcolepsy	0.00022	0.000517	CbGpPWpGaD
Crizotinib—MAPK7—Signaling Pathways—NPS—narcolepsy	0.00022	0.000516	CbGpPWpGaD
Crizotinib—MAPK7—Signaling Pathways—TAC1—narcolepsy	0.00022	0.000516	CbGpPWpGaD
Crizotinib—YES1—Adaptive Immune System—HLA-DQA1—narcolepsy	0.00022	0.000516	CbGpPWpGaD
Crizotinib—LYN—Cytokine Signaling in Immune system—HLA-DRB1—narcolepsy	0.000217	0.000508	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—PENK—narcolepsy	0.000214	0.000503	CbGpPWpGaD
Crizotinib—JAK2—Signaling by GPCR—PENK—narcolepsy	0.000214	0.000502	CbGpPWpGaD
Crizotinib—TBK1—Immune System—HLA-DQA1—narcolepsy	0.000214	0.000501	CbGpPWpGaD
Crizotinib—TYK2—Signaling by GPCR—HRH3—narcolepsy	0.000211	0.000494	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—HCRT—narcolepsy	0.000206	0.000484	CbGpPWpGaD
Crizotinib—YES1—Adaptive Immune System—HLA-DQB1—narcolepsy	0.000206	0.000482	CbGpPWpGaD
Crizotinib—MAP3K3—Immune System—HLA-DQA1—narcolepsy	0.000205	0.000481	CbGpPWpGaD
Crizotinib—IKBKE—Immune System—HLA-DRB1—narcolepsy	0.000205	0.00048	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—HCRT—narcolepsy	0.000204	0.000477	CbGpPWpGaD
Crizotinib—JAK2—Cytokine Signaling in Immune system—HLA-DRB1—narcolepsy	0.000203	0.000475	CbGpPWpGaD
Crizotinib—RIPK2—Adaptive Immune System—HLA-DRB1—narcolepsy	0.000202	0.000474	CbGpPWpGaD
Crizotinib—JAK2—GPCR downstream signaling—TRH—narcolepsy	0.000201	0.00047	CbGpPWpGaD
Crizotinib—TBK1—Immune System—HLA-DQB1—narcolepsy	0.0002	0.000469	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—TRH—narcolepsy	0.000199	0.000467	CbGpPWpGaD
Crizotinib—ACVR1B—Signaling Pathways—HTR2A—narcolepsy	0.000197	0.000462	CbGpPWpGaD
Crizotinib—FER—Signaling Pathways—HTR2A—narcolepsy	0.000197	0.000462	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—TRH—narcolepsy	0.000196	0.00046	CbGpPWpGaD
Crizotinib—JAK3—Signaling Pathways—HRH3—narcolepsy	0.000196	0.00046	CbGpPWpGaD
Crizotinib—BLK—Adaptive Immune System—HLA-DRB1—narcolepsy	0.000194	0.000456	CbGpPWpGaD
Crizotinib—JAK3—Immune System—HLA-DQA1—narcolepsy	0.000193	0.000453	CbGpPWpGaD
Crizotinib—FES—Developmental Biology—TNF—narcolepsy	0.000193	0.000453	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—HCRT—narcolepsy	0.000193	0.000452	CbGpPWpGaD
Crizotinib—MAP3K3—Immune System—HLA-DQB1—narcolepsy	0.000192	0.00045	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—TRH—narcolepsy	0.000188	0.000441	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—HCRT—narcolepsy	0.000187	0.000439	CbGpPWpGaD
Crizotinib—AXL—Signaling Pathways—HTR2A—narcolepsy	0.000187	0.000438	CbGpPWpGaD
Crizotinib—MAPK7—Immune System—HLA-DRB1—narcolepsy	0.000186	0.000436	CbGpPWpGaD
Crizotinib—LIMK1—Immune System—HLA-DRB1—narcolepsy	0.000186	0.000436	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—HCRTR1—narcolepsy	0.000185	0.000433	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—HCRTR2—narcolepsy	0.000185	0.000433	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—PENK—narcolepsy	0.000184	0.000431	CbGpPWpGaD
Crizotinib—EPHA5—Developmental Biology—TNF—narcolepsy	0.000183	0.00043	CbGpPWpGaD
Crizotinib—EPHA3—Developmental Biology—TNF—narcolepsy	0.000183	0.00043	CbGpPWpGaD
Crizotinib—ABL2—Developmental Biology—TNF—narcolepsy	0.000183	0.00043	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—TRH—narcolepsy	0.000182	0.000427	CbGpPWpGaD
Crizotinib—JAK3—GPCR downstream signaling—HTR2A—narcolepsy	0.000182	0.000427	CbGpPWpGaD
Crizotinib—JAK2—Signaling by GPCR—TRH—narcolepsy	0.000182	0.000427	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—PENK—narcolepsy	0.000181	0.000425	CbGpPWpGaD
Crizotinib—JAK3—Immune System—HLA-DQB1—narcolepsy	0.000181	0.000424	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—P2RY11—narcolepsy	0.000178	0.000418	CbGpPWpGaD
Crizotinib—LCK—Cytokine Signaling in Immune system—HLA-DRB1—narcolepsy	0.000178	0.000416	CbGpPWpGaD
Crizotinib—EPHA8—Developmental Biology—TNF—narcolepsy	0.000177	0.000414	CbGpPWpGaD
Crizotinib—JAK2—GPCR downstream signaling—HRH3—narcolepsy	0.000176	0.000412	CbGpPWpGaD
Crizotinib—EPHB4—Developmental Biology—TNF—narcolepsy	0.000175	0.00041	CbGpPWpGaD
Crizotinib—EPHA4—Developmental Biology—TNF—narcolepsy	0.000175	0.00041	CbGpPWpGaD
Crizotinib—LIMK2—Developmental Biology—TNF—narcolepsy	0.000175	0.00041	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—HRH3—narcolepsy	0.000175	0.00041	CbGpPWpGaD
Crizotinib—TYK2—Signaling by GPCR—NPS—narcolepsy	0.000175	0.000409	CbGpPWpGaD
Crizotinib—TYK2—Signaling by GPCR—TAC1—narcolepsy	0.000175	0.000409	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—HCRTR2—narcolepsy	0.000173	0.000405	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—HCRTR1—narcolepsy	0.000173	0.000405	CbGpPWpGaD
Crizotinib—RIPK2—Immune System—HLA-DQA1—narcolepsy	0.000172	0.000404	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—HRH3—narcolepsy	0.000172	0.000404	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—PENK—narcolepsy	0.000172	0.000403	CbGpPWpGaD
Crizotinib—LIMK1—Developmental Biology—TNF—narcolepsy	0.000171	0.000401	CbGpPWpGaD
Crizotinib—BMPR1B—Signaling Pathways—HTR2A—narcolepsy	0.000171	0.000401	CbGpPWpGaD
Crizotinib—PTK2B—Immune System—HLA-DQA1—narcolepsy	0.00017	0.000398	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—PENK—narcolepsy	0.000167	0.000392	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—P2RY11—narcolepsy	0.000167	0.000392	CbGpPWpGaD
Crizotinib—BLK—Immune System—HLA-DQA1—narcolepsy	0.000166	0.000389	CbGpPWpGaD
Crizotinib—JAK3—Signaling by GPCR—HTR2A—narcolepsy	0.000165	0.000388	CbGpPWpGaD
Crizotinib—FGR—Immune System—HLA-DQA1—narcolepsy	0.000165	0.000387	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—HRH3—narcolepsy	0.000165	0.000386	CbGpPWpGaD
Crizotinib—EPHB6—Developmental Biology—TNF—narcolepsy	0.000164	0.000385	CbGpPWpGaD
Crizotinib—LYN—Adaptive Immune System—HLA-DQA1—narcolepsy	0.000164	0.000384	CbGpPWpGaD
Crizotinib—JAK3—Signaling Pathways—NPS—narcolepsy	0.000162	0.000381	CbGpPWpGaD
Crizotinib—JAK3—Signaling Pathways—TAC1—narcolepsy	0.000162	0.000381	CbGpPWpGaD
Crizotinib—RIPK2—Immune System—HLA-DQB1—narcolepsy	0.000161	0.000378	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—HRH3—narcolepsy	0.00016	0.000375	CbGpPWpGaD
Crizotinib—JAK2—Signaling by GPCR—HRH3—narcolepsy	0.00016	0.000374	CbGpPWpGaD
Crizotinib—PTK2B—Immune System—HLA-DQB1—narcolepsy	0.000159	0.000372	CbGpPWpGaD
Crizotinib—YES1—Adaptive Immune System—HLA-DRB1—narcolepsy	0.000156	0.000367	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—TRH—narcolepsy	0.000156	0.000367	CbGpPWpGaD
Crizotinib—BLK—Immune System—HLA-DQB1—narcolepsy	0.000155	0.000364	CbGpPWpGaD
Crizotinib—FGR—Immune System—HLA-DQB1—narcolepsy	0.000155	0.000362	CbGpPWpGaD
Crizotinib—EPHA6—Developmental Biology—TNF—narcolepsy	0.000155	0.000362	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—TRH—narcolepsy	0.000154	0.000362	CbGpPWpGaD
Crizotinib—LYN—Adaptive Immune System—HLA-DQB1—narcolepsy	0.000153	0.00036	CbGpPWpGaD
Crizotinib—TBK1—Immune System—HLA-DRB1—narcolepsy	0.000152	0.000357	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—HCRT—narcolepsy	0.000152	0.000356	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—HCRTR2—narcolepsy	0.000151	0.000355	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—HCRTR1—narcolepsy	0.000151	0.000355	CbGpPWpGaD
Crizotinib—FES—Signaling Pathways—HTR2A—narcolepsy	0.00015	0.00035	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—P2RY11—narcolepsy	0.000146	0.000343	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—TRH—narcolepsy	0.000146	0.000343	CbGpPWpGaD
Crizotinib—MAP3K3—Immune System—HLA-DRB1—narcolepsy	0.000146	0.000342	CbGpPWpGaD
Crizotinib—JAK2—GPCR downstream signaling—TAC1—narcolepsy	0.000146	0.000342	CbGpPWpGaD
Crizotinib—JAK2—GPCR downstream signaling—NPS—narcolepsy	0.000146	0.000342	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—TAC1—narcolepsy	0.000145	0.000339	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—NPS—narcolepsy	0.000145	0.000339	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—CHKB—narcolepsy	0.000143	0.000335	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—TAC1—narcolepsy	0.000143	0.000335	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—NPS—narcolepsy	0.000143	0.000335	CbGpPWpGaD
Crizotinib—EPHA2—Developmental Biology—TNF—narcolepsy	0.000143	0.000334	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—HCRT—narcolepsy	0.000142	0.000333	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—TRH—narcolepsy	0.000142	0.000333	CbGpPWpGaD
Crizotinib—ABL1—Integrated Pancreatic Cancer Pathway—TNF—narcolepsy	0.000138	0.000324	CbGpPWpGaD
Crizotinib—JAK3—Immune System—HLA-DRB1—narcolepsy	0.000138	0.000322	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—HRH3—narcolepsy	0.000137	0.000321	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—NPS—narcolepsy	0.000137	0.00032	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—TAC1—narcolepsy	0.000137	0.00032	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—PENK—narcolepsy	0.000135	0.000317	CbGpPWpGaD
Crizotinib—PTK2—Immune System—HLA-DQA1—narcolepsy	0.000135	0.000317	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—HRH3—narcolepsy	0.000135	0.000317	CbGpPWpGaD
Crizotinib—IGF1R—Signaling Pathways—HTR2A—narcolepsy	0.000135	0.000317	CbGpPWpGaD
Crizotinib—LCK—Adaptive Immune System—HLA-DQA1—narcolepsy	0.000134	0.000315	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—HCRTR1—narcolepsy	0.000134	0.000314	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—HCRTR2—narcolepsy	0.000134	0.000314	CbGpPWpGaD
Crizotinib—YES1—Immune System—HLA-DQA1—narcolepsy	0.000133	0.000313	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—NPS—narcolepsy	0.000132	0.00031	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—TAC1—narcolepsy	0.000132	0.00031	CbGpPWpGaD
Crizotinib—JAK2—Signaling by GPCR—NPS—narcolepsy	0.000132	0.00031	CbGpPWpGaD
Crizotinib—JAK2—Signaling by GPCR—TAC1—narcolepsy	0.000132	0.00031	CbGpPWpGaD
Crizotinib—MAPK7—Signaling Pathways—HTR2A—narcolepsy	0.000132	0.00031	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—P2RY11—narcolepsy	0.00013	0.000304	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—HRH3—narcolepsy	0.000128	0.000301	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—PENK—narcolepsy	0.000127	0.000297	CbGpPWpGaD
Crizotinib—IRAK1—Immune System—HLA-DQA1—narcolepsy	0.000127	0.000297	CbGpPWpGaD
Crizotinib—PTK2—Immune System—HLA-DQB1—narcolepsy	0.000127	0.000297	CbGpPWpGaD
Crizotinib—LCK—Adaptive Immune System—HLA-DQB1—narcolepsy	0.000126	0.000295	CbGpPWpGaD
Crizotinib—YES1—Immune System—HLA-DQB1—narcolepsy	0.000125	0.000292	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—HRH3—narcolepsy	0.000125	0.000292	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—HCRT—narcolepsy	0.000124	0.000292	CbGpPWpGaD
Crizotinib—TYK2—Immune System—HLA-DQA1—narcolepsy	0.000123	0.000288	CbGpPWpGaD
Crizotinib—RIPK2—Immune System—HLA-DRB1—narcolepsy	0.000123	0.000287	CbGpPWpGaD
Crizotinib—ABCB1—Allograft Rejection—TNF—narcolepsy	0.000121	0.000284	CbGpPWpGaD
Crizotinib—PTK2B—Immune System—HLA-DRB1—narcolepsy	0.000121	0.000283	CbGpPWpGaD
Crizotinib—SRC—Adaptive Immune System—HLA-DQA1—narcolepsy	0.000119	0.000279	CbGpPWpGaD
Crizotinib—IRAK1—Immune System—HLA-DQB1—narcolepsy	0.000118	0.000277	CbGpPWpGaD
Crizotinib—BLK—Immune System—HLA-DRB1—narcolepsy	0.000118	0.000276	CbGpPWpGaD
Crizotinib—FGR—Immune System—HLA-DRB1—narcolepsy	0.000118	0.000276	CbGpPWpGaD
Crizotinib—LYN—Adaptive Immune System—HLA-DRB1—narcolepsy	0.000117	0.000273	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—TRH—narcolepsy	0.000115	0.00027	CbGpPWpGaD
Crizotinib—TYK2—Immune System—HLA-DQB1—narcolepsy	0.000115	0.000269	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—NPS—narcolepsy	0.000114	0.000266	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—TAC1—narcolepsy	0.000114	0.000266	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—NPS—narcolepsy	0.000112	0.000263	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—TAC1—narcolepsy	0.000112	0.000263	CbGpPWpGaD
Crizotinib—SRC—Adaptive Immune System—HLA-DQB1—narcolepsy	0.000111	0.000261	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—PENK—narcolepsy	0.000111	0.00026	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—HCRT—narcolepsy	0.00011	0.000258	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—CHKB—narcolepsy	0.000108	0.000253	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—TRH—narcolepsy	0.000108	0.000252	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—NPS—narcolepsy	0.000106	0.000249	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—TAC1—narcolepsy	0.000106	0.000249	CbGpPWpGaD
Crizotinib—TYK2—Signaling by GPCR—HTR2A—narcolepsy	0.000105	0.000246	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—TAC1—narcolepsy	0.000103	0.000242	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—NPS—narcolepsy	0.000103	0.000242	CbGpPWpGaD
Crizotinib—SRC—Integrated Pancreatic Cancer Pathway—TNF—narcolepsy	0.000101	0.000236	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—HRH3—narcolepsy	0.000101	0.000236	CbGpPWpGaD
Crizotinib—LYN—Immune System—HLA-DQA1—narcolepsy	9.95e-05	0.000233	CbGpPWpGaD
Crizotinib—ABL1—Immune System—HLA-DQA1—narcolepsy	9.9e-05	0.000232	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—PENK—narcolepsy	9.82e-05	0.00023	CbGpPWpGaD
Crizotinib—JAK3—Signaling Pathways—HTR2A—narcolepsy	9.78e-05	0.000229	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—CPT1B—narcolepsy	9.71e-05	0.000228	CbGpPWpGaD
Crizotinib—PTK2—Immune System—HLA-DRB1—narcolepsy	9.62e-05	0.000225	CbGpPWpGaD
Crizotinib—LCK—Adaptive Immune System—HLA-DRB1—narcolepsy	9.56e-05	0.000224	CbGpPWpGaD
Crizotinib—YES1—Immune System—HLA-DRB1—narcolepsy	9.49e-05	0.000222	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—HRH3—narcolepsy	9.44e-05	0.000221	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—TRH—narcolepsy	9.43e-05	0.000221	CbGpPWpGaD
Crizotinib—JAK2—Immune System—HLA-DQA1—narcolepsy	9.31e-05	0.000218	CbGpPWpGaD
Crizotinib—LYN—Immune System—HLA-DQB1—narcolepsy	9.3e-05	0.000218	CbGpPWpGaD
Crizotinib—ABL1—Immune System—HLA-DQB1—narcolepsy	9.26e-05	0.000217	CbGpPWpGaD
Crizotinib—IRAK1—Immune System—HLA-DRB1—narcolepsy	9e-05	0.000211	CbGpPWpGaD
Crizotinib—PTK2—Developmental Biology—TNF—narcolepsy	8.84e-05	0.000207	CbGpPWpGaD
Crizotinib—JAK2—GPCR downstream signaling—HTR2A—narcolepsy	8.77e-05	0.000206	CbGpPWpGaD
Crizotinib—TYK2—Immune System—HLA-DRB1—narcolepsy	8.74e-05	0.000205	CbGpPWpGaD
Crizotinib—YES1—Developmental Biology—TNF—narcolepsy	8.72e-05	0.000204	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—HTR2A—narcolepsy	8.71e-05	0.000204	CbGpPWpGaD
Crizotinib—JAK2—Immune System—HLA-DQB1—narcolepsy	8.71e-05	0.000204	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—HTR2A—narcolepsy	8.59e-05	0.000201	CbGpPWpGaD
Crizotinib—SRC—Adaptive Immune System—HLA-DRB1—narcolepsy	8.46e-05	0.000198	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—NPS—narcolepsy	8.36e-05	0.000196	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—TAC1—narcolepsy	8.36e-05	0.000196	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—TRH—narcolepsy	8.35e-05	0.000196	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—HRH3—narcolepsy	8.27e-05	0.000194	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—HTR2A—narcolepsy	8.22e-05	0.000193	CbGpPWpGaD
Crizotinib—LCK—Immune System—HLA-DQA1—narcolepsy	8.15e-05	0.000191	CbGpPWpGaD
Crizotinib—TYK2—Developmental Biology—TNF—narcolepsy	8.03e-05	0.000188	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—HTR2A—narcolepsy	7.97e-05	0.000187	CbGpPWpGaD
Crizotinib—JAK2—Signaling by GPCR—HTR2A—narcolepsy	7.96e-05	0.000187	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—TAC1—narcolepsy	7.82e-05	0.000183	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—NPS—narcolepsy	7.82e-05	0.000183	CbGpPWpGaD
Crizotinib—LCK—Immune System—HLA-DQB1—narcolepsy	7.63e-05	0.000179	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—CPT1B—narcolepsy	7.33e-05	0.000172	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—HRH3—narcolepsy	7.32e-05	0.000172	CbGpPWpGaD
Crizotinib—SRC—Immune System—HLA-DQA1—narcolepsy	7.22e-05	0.000169	CbGpPWpGaD
Crizotinib—LYN—Immune System—HLA-DRB1—narcolepsy	7.07e-05	0.000166	CbGpPWpGaD
Crizotinib—ABL1—Immune System—HLA-DRB1—narcolepsy	7.04e-05	0.000165	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—TAC1—narcolepsy	6.85e-05	0.000161	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—NPS—narcolepsy	6.85e-05	0.000161	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—HTR2A—narcolepsy	6.84e-05	0.00016	CbGpPWpGaD
Crizotinib—SRC—Immune System—HLA-DQB1—narcolepsy	6.75e-05	0.000158	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—HTR2A—narcolepsy	6.74e-05	0.000158	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—CHKB—narcolepsy	6.64e-05	0.000156	CbGpPWpGaD
Crizotinib—JAK2—Immune System—HLA-DRB1—narcolepsy	6.62e-05	0.000155	CbGpPWpGaD
Crizotinib—LYN—Developmental Biology—TNF—narcolepsy	6.5e-05	0.000152	CbGpPWpGaD
Crizotinib—ABL1—Developmental Biology—TNF—narcolepsy	6.47e-05	0.000152	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—HTR2A—narcolepsy	6.4e-05	0.00015	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—HTR2A—narcolepsy	6.21e-05	0.000146	CbGpPWpGaD
Crizotinib—JAK2—Developmental Biology—TNF—narcolepsy	6.08e-05	0.000143	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—TAC1—narcolepsy	6.06e-05	0.000142	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—NPS—narcolepsy	6.06e-05	0.000142	CbGpPWpGaD
Crizotinib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—narcolepsy	5.97e-05	0.00014	CbGpPWpGaD
Crizotinib—LCK—Immune System—HLA-DRB1—narcolepsy	5.8e-05	0.000136	CbGpPWpGaD
Crizotinib—SRC—Immune System—HLA-DRB1—narcolepsy	5.13e-05	0.00012	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—HTR2A—narcolepsy	5.03e-05	0.000118	CbGpPWpGaD
Crizotinib—SRC—Developmental Biology—TNF—narcolepsy	4.72e-05	0.000111	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—HTR2A—narcolepsy	4.71e-05	0.00011	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—CPT1B—narcolepsy	4.51e-05	0.000106	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—HTR2A—narcolepsy	4.12e-05	9.66e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—HTR2A—narcolepsy	3.65e-05	8.55e-05	CbGpPWpGaD
